… Rituximab, depleting B cells, may reduce immune complexes containing IgA during IgA
vasculitis and reduce disease activity. Only 4 case series of patients treated with rituximab are …

… Underlying condition SOT SOT B-cell neoplasm Connective tissue disease ASCT ASCT B-…
Underlying condition SOT SOT B-cell neoplasm Connective tissue disease ASCT ASCT B-cell …

… Benjamin Terrier received a financial support from the Direction régionale des Affaires
Sanitaires et Sociales. Philippe Guilpain is on a grant from the “Fondation pour la Recherche …

… (F) Proportions of CD19 + B cells among lymphocytes and CD38hi CD27hi plasmablasts
among CD19 + B cells. (G) Analysis of the functional status of specific T cell subsets and NK …

INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …

… b, Anti-S IgG levels in sera of individuals before PrEP (naive; n = 11), treated with … c,
Sero-neutralization of Delta and Omicron BA.1 and BA.2 in the same individuals as in b. Two-sided …

… disease likely to result in decompensation during a viral infection; heart failure (New York
Heart Association class III or IV); chronic kidney disease; liver cirrhosis with Child-Pugh class B …

Background A new autoinflammatory syndrome related to somatic mutations of UBA1 was
recently described and called VEXAS syndrome (‘Vacuoles, E1 Enzyme, X‐linked, …

… B cells play a multifaceted role, acting as antigen-presenting cells and producing pathogenic
autoantibodies, cytokines, and chemokines, which supports the use of B cell depletion …

… Benjamin Terrier … 3a, b, c). In contrast, angiopoietin-2 levels were significantly associated
with CRP, creatinine and D-dimers (respectively with p value at 0.001, 0.001 … Benjamin Terrier …